Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
0.4962
-0.0188 (-3.65%)
At close: Apr 2, 2025, 4:00 PM
0.5195
+0.0232 (4.69%)
After-hours: Apr 2, 2025, 7:56 PM EDT

Indaptus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-15.02-15.42-14.32-7.71-3.58
Upgrade
Depreciation & Amortization
00000
Upgrade
Loss (Gain) From Sale of Assets
---0.02--
Upgrade
Stock-Based Compensation
2.312.972.961.510.14
Upgrade
Other Operating Activities
--0.43-0.11--
Upgrade
Change in Accounts Payable
0.47-0.68-1.15-4.240.11
Upgrade
Change in Other Net Operating Assets
-0.080.16-0.43-0.850
Upgrade
Operating Cash Flow
-12.32-13.41-13.08-11.29-3.32
Upgrade
Capital Expenditures
----0-
Upgrade
Sale of Property, Plant & Equipment
--0.170.45-
Upgrade
Investment in Securities
-17.14-16.6--
Upgrade
Investing Cash Flow
-17.14-16.430.45-
Upgrade
Issuance of Common Stock
5.51--0.39-
Upgrade
Other Financing Activities
-0.76--47.951.16
Upgrade
Financing Cash Flow
4.75--48.341.16
Upgrade
Net Cash Flow
-7.583.74-29.5137.49-2.16
Upgrade
Free Cash Flow
-12.32-13.41-13.08-11.29-3.32
Upgrade
Free Cash Flow Per Share
-1.32-1.60-1.58-2.76-1.71
Upgrade
Cash Income Tax Paid
00000
Upgrade
Levered Free Cash Flow
-6.86-7.77-7.07-1.99-0.82
Upgrade
Unlevered Free Cash Flow
-6.86-7.77-7.07-1.99-0.82
Upgrade
Change in Net Working Capital
-0.440.50.71-1.33-1.28
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q